132 related articles for article (PubMed ID: 34147517)
21. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
[TBL] [Abstract][Full Text] [Related]
22. Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous Form and Solubility Enhancement in Solution.
Lalge R; Kaur N; Duggirala NK; Suryanarayanan R
Mol Pharm; 2022 Jul; 19(7):2595-2606. PubMed ID: 35687125
[TBL] [Abstract][Full Text] [Related]
23. Understanding Dissolution and Crystallization with Imaging: A Surface Point of View.
Novakovic D; Isomäki A; Pleunis B; Fraser-Miller SJ; Peltonen L; Laaksonen T; Strachan CJ
Mol Pharm; 2018 Nov; 15(11):5361-5373. PubMed ID: 30247922
[TBL] [Abstract][Full Text] [Related]
24. Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth.
Luo M; Chen A; Huang C; Guo M; Cai T
Mol Pharm; 2024 Jul; 21(7):3591-3602. PubMed ID: 38818946
[TBL] [Abstract][Full Text] [Related]
25. Development of Maltodextrin-Based Immediate-Release Tablets Using an Integrated Twin-Screw Hot-Melt Extrusion and Injection-Molding Continuous Manufacturing Process.
Puri V; Brancazio D; Desai PM; Jensen KD; Chun JH; Myerson AS; Trout BL
J Pharm Sci; 2017 Nov; 106(11):3328-3336. PubMed ID: 28684263
[TBL] [Abstract][Full Text] [Related]
26. [Construction of Coamorphous Technology Aimed at Improving Membrane Permeability and Application to Emulsion].
Uchiyama H
Yakugaku Zasshi; 2021; 141(11):1223-1228. PubMed ID: 34719541
[TBL] [Abstract][Full Text] [Related]
27. Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.
Jensen KT; Larsen FH; Cornett C; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2015 Jul; 12(7):2484-92. PubMed ID: 26057950
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
[TBL] [Abstract][Full Text] [Related]
29. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
[TBL] [Abstract][Full Text] [Related]
30. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
31. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
32. Cocrystal formation of loratadine-succinic acid and its improved solubility.
Setyawan D; Adyaksa FR; Sari HL; Paramita DP; Sari R
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):623-630. PubMed ID: 34214360
[TBL] [Abstract][Full Text] [Related]
33. Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.
Shayanfar A; Ghavimi H; Hamishekar H; Jouyban A
J Pharm Pharm Sci; 2013; 16(4):577-87. PubMed ID: 24210065
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.
Fang X; Hu Y; Huang Z; Han L; Li B; Lu S; Cao Y
J Pharm Sci; 2022 Jul; 111(7):2056-2071. PubMed ID: 35167885
[TBL] [Abstract][Full Text] [Related]
35. Dicarboxylic acid as a linker to improve the content of amorphous drug in drug-in-polymer film: Effects of molecular mobility, electrical conductivity and intermolecular interactions.
Quan P; Wan X; Tian Q; Liu C; Fang L
J Control Release; 2020 Jan; 317():142-153. PubMed ID: 31785302
[TBL] [Abstract][Full Text] [Related]
36. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
37. A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.
Su M; Xia Y; Shen Y; Heng W; Wei Y; Zhang L; Gao Y; Zhang J; Qian S
RSC Adv; 2019 Dec; 10(1):565-583. PubMed ID: 35492562
[TBL] [Abstract][Full Text] [Related]
38. Influence of the p
Hu Y; Guo Y; Li B; Xu R; Fang X; Cao Y; Liu Z; Jiang C; Lu S
ACS Omega; 2021 Feb; 6(4):3106-3119. PubMed ID: 33553927
[TBL] [Abstract][Full Text] [Related]
39. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
